Literature DB >> 21903770

Disruptive TP53 mutation is associated with aggressive disease characteristics in an orthotopic murine model of oral tongue cancer.

Daisuke Sano1, Tong-Xin Xie, Thomas J Ow, Mei Zhao, Curtis R Pickering, Ge Zhou, Vlad C Sandulache, David A Wheeler, Richard A Gibbs, Carlos Caulin, Jeffrey N Myers.   

Abstract

PURPOSE: To characterize tumor growth and metastatic potential in head and neck squamous cell carcinoma (HNSCC) cell lines in an orthotopic murine model of oral tongue cancer and to correlate TP53 mutation status with these findings. EXPERIMENTAL
DESIGN: Cells from each of 48 HNSCC cell lines were orthotopically injected into the oral tongues of nude mice. Tumor volume, cervical lymph node metastasis, and mouse survival were recorded. Direct sequencing of the TP53 gene and Western blot analysis for the p53 protein after induction with 5-fluorouracil was conducted. Cell lines were categorized as either mutant TP53 or wild-type TP53, and lines with TP53 mutation were further categorized on the basis of type of mutation (disruptive or nondisruptive) and level of p53 protein expression. The behavior of tumors in these different groups was compared.
RESULTS: These 48 HNSCC cell lines showed a wide range of behavior from highly aggressive and metastatic to no tumor formation. Mice injected with cells harboring disruptive TP53 mutations had faster tumor growth, greater incidence of cervical lymph node metastasis, and shorter survival than mice injected with cells lacking these mutations.
CONCLUSIONS: HNSCC cell lines display a wide spectrum of behavior in an orthotopic model of oral cancer. Cell lines with disruptive TP53 mutations are more aggressive in this system, corroborating clinical reports that have linked these mutations to poor patient outcome. ©2011 AACR

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21903770      PMCID: PMC3207013          DOI: 10.1158/1078-0432.CCR-11-0046

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  27 in total

1.  Short tandem repeat profiling provides an international reference standard for human cell lines.

Authors:  J R Masters; J A Thomson; B Daly-Burns; Y A Reid; W G Dirks; P Packer; L H Toji; T Ohno; H Tanabe; C F Arlett; L R Kelland; M Harrison; A Virmani; T H Ward; K L Ayres; P G Debenham
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

Review 2.  Head and neck cancer.

Authors:  A Forastiere; W Koch; A Trotti; D Sidransky
Journal:  N Engl J Med       Date:  2001-12-27       Impact factor: 91.245

Review 3.  Emerging molecular markers of cancer.

Authors:  David Sidransky
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

4.  p53 gene status as a predictor of tumor response to induction chemotherapy of patients with locoregionally advanced squamous cell carcinomas of the head and neck.

Authors:  S Temam; A Flahault; S Périé; G Monceaux; F Coulet; P Callard; J F Bernaudin; J L St Guily; P Fouret
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

5.  An orthotopic nude mouse model of oral tongue squamous cell carcinoma.

Authors:  Jeffrey N Myers; F Christopher Holsinger; Samar A Jasser; B Nebiyou Bekele; Isaiah J Fidler
Journal:  Clin Cancer Res       Date:  2002-01       Impact factor: 12.531

6.  p53 alterations predict tumor response to neoadjuvant chemotherapy in head and neck squamous cell carcinoma: a prospective series.

Authors:  A Cabelguenne; H Blons; I de Waziers; F Carnot; A M Houllier; T Soussi; D Brasnu; P Beaune; O Laccourreye; P Laurent-Puig
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

7.  Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Authors:  Mei Zhao; Daisuke Sano; Curtis R Pickering; Samar A Jasser; Ying C Henderson; Gary L Clayman; Erich M Sturgis; Thomas J Ow; Reuben Lotan; Thomas E Carey; Peter G Sacks; Jennifer R Grandis; David Sidransky; Nils Erik Heldin; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2011-08-25       Impact factor: 12.531

8.  A transactivation-deficient mouse model provides insights into Trp53 regulation and function.

Authors:  G S Jimenez; M Nister; J M Stommel; M Beeche; E A Barcarse; X Q Zhang; S O'Gorman; G M Wahl
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  The impact of p53 protein core domain structural alteration on ovarian cancer survival.

Authors:  Stephen L Rose; Andrew D Robertson; Michael J Goodheart; Brian J Smith; Barry R DeYoung; Richard E Buller
Journal:  Clin Cancer Res       Date:  2003-09-15       Impact factor: 12.531

10.  Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis.

Authors:  Shunsuke Kato; Shuang-Yin Han; Wen Liu; Kazunori Otsuka; Hiroyuki Shibata; Ryunosuke Kanamaru; Chikashi Ishioka
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-25       Impact factor: 11.205

View more
  50 in total

1.  Gain-of-function mutant p53 promotes cell growth and cancer cell metabolism via inhibition of AMPK activation.

Authors:  Ge Zhou; Jiping Wang; Mei Zhao; Tong-Xin Xie; Noriaki Tanaka; Daisuke Sano; Ameeta A Patel; Alexandra M Ward; Vlad C Sandulache; Samar A Jasser; Heath D Skinner; Alison Lea Fitzgerald; Abdullah A Osman; Yongkun Wei; Xuefeng Xia; Zhou Songyang; Gordon B Mills; Mien-Chie Hung; Carlos Caulin; Jiyong Liang; Jeffrey N Myers
Journal:  Mol Cell       Date:  2014-05-22       Impact factor: 17.970

Review 2.  TP53 Mutations in Head and Neck Squamous Cell Carcinoma and Their Impact on Disease Progression and Treatment Response.

Authors:  Ge Zhou; Zhiyi Liu; Jeffrey N Myers
Journal:  J Cell Biochem       Date:  2016-06-03       Impact factor: 4.429

3.  CHK it out! Blocking WEE kinase routs TP53 mutant cancer.

Authors:  Julie E Bauman; Christine H Chung
Journal:  Clin Cancer Res       Date:  2014-08-15       Impact factor: 12.531

4.  Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites.

Authors:  Mei Zhao; Daisuke Sano; Curtis R Pickering; Samar A Jasser; Ying C Henderson; Gary L Clayman; Erich M Sturgis; Thomas J Ow; Reuben Lotan; Thomas E Carey; Peter G Sacks; Jennifer R Grandis; David Sidransky; Nils Erik Heldin; Jeffrey N Myers
Journal:  Clin Cancer Res       Date:  2011-08-25       Impact factor: 12.531

5.  A functional variant at the miR-885-5p binding site of CASP3 confers risk of both index and second primary malignancies in patients with head and neck cancer.

Authors:  Xiaoxiang Guan; Zhensheng Liu; Hongliang Liu; Hongping Yu; Li-E Wang; Erich M Sturgis; Guojun Li; Qingyi Wei
Journal:  FASEB J       Date:  2012-12-27       Impact factor: 5.191

6.  Intraoperative diagnostics and elimination of residual microtumours with plasmonic nanobubbles.

Authors:  Ekaterina Y Lukianova-Hleb; Yoo-Shin Kim; Ihor Belatsarkouski; Ann M Gillenwater; Brian E O'Neill; Dmitri O Lapotko
Journal:  Nat Nanotechnol       Date:  2016-02-15       Impact factor: 39.213

7.  Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models.

Authors:  Barbara A Frederick; Rohit Gupta; Amandla Atilano-Roque; Tin Tin Su; David Raben
Journal:  Radiat Res       Date:  2020-11-10       Impact factor: 2.841

8.  Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.

Authors:  Naoshad Muhammad; Sourav Bhattacharya; Robert Steele; Nancy Phillips; Ratna B Ray
Journal:  Clin Cancer Res       Date:  2016-12-13       Impact factor: 12.531

9.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.

Authors:  Curtis R Pickering; Jiexin Zhang; Suk Young Yoo; Linnea Bengtsson; Shhyam Moorthy; David M Neskey; Mei Zhao; Marcus V Ortega Alves; Kyle Chang; Jennifer Drummond; Elsa Cortez; Tong-Xin Xie; Di Zhang; Woonbok Chung; Jean-Pierre J Issa; Patrick A Zweidler-McKay; Xifeng Wu; Adel K El-Naggar; John N Weinstein; Jing Wang; Donna M Muzny; Richard A Gibbs; David A Wheeler; Jeffrey N Myers; Mitchell J Frederick
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

10.  Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Authors:  Dhruv Kumar; Jacob New; Vikalp Vishwakarma; Radhika Joshi; Jonathan Enders; Fangchen Lin; Sumana Dasari; Wade R Gutierrez; George Leef; Sivapriya Ponnurangam; Hemantkumar Chavan; Lydia Ganaden; Mackenzie M Thornton; Hongying Dai; Ossama Tawfik; Jeffrey Straub; Yelizaveta Shnayder; Kiran Kakarala; Terance Ted Tsue; Douglas A Girod; Bennett Van Houten; Shrikant Anant; Partha Krishnamurthy; Sufi Mary Thomas
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.